The impact of interferon-free direct-acting antivirals on clinical outcome after curative treatment for hepatitis C virus-associated hepatocellular carcinoma: Comparison with interferon-based therapy.
Yuko NagaokiMichio ImamuraYuno NishidaKana DaijoYuji TeraokaFumi HondaYuki NakamuraKei MorioHatsue FujinoTakashi NakaharaTomokazu KawaokaMasataka TsugeAkira HiramatsuYoshiiku KawakamiDaiki MikiYuichi HiyamaHidenori OchiKazuaki ChayamaHiroshi AikataPublished in: Journal of medical virology (2018)
We found that SVR obtained after curative treatment for primary HCC suppressed recurrence and improved overall survival. And, IFN-free DAA therapy after curative treatment for primary HCC could predict improving overall survival and suppressed HCC recurrence.